Skip to content
Open access

HAMSIAA protects cyclophosphamide induced immunosuppression by modulating gut homeostasis and purine metabolism

Sep 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 38 references
Medicine

TL;DR

The present findings suggest that HAMSIAA is a promising functional food ingredient for the prophylactic mitigation of chemotherapy induced immunosuppression, and provide support for its translational application in the field of immunonutrition.

Abstract

Introduction Dietary supplementation with functional starches serves as a promising intervention strategy for immune regulation, yet the immunomodulatory efficacy and underlying mechanisms of newly developed modified starch derivatives remain to be further explored. In this study, a cyclophosphamide (CTX) induced secondary immunodeficiency mouse model was adopted to investigate the immunoregulatory effects of indole 3 acetylated high amylose maize starch derivative (HAMSIAA). Methods Mice were fed a basal diet supplemented with 0.5% or 1% HAMSIAA for nine consecutive days, with CTX administered starting on day 7. Immune organ injury, splenic CD4⁺/CD8⁺ T cell balance, serum immunoglobulins, intestinal barrier integrity, gut microbiota composition and purine related metabolome were assessed. Results HAMSIAA attenuated CTX triggered damage to immune organs, maintained the splenic CD4⁺/CD8⁺ T cell balance, and increased serum levels of Immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM). In addition, HAMSIAA improved intestinal barrier integrity and modulated gut microbiota composition, as evidenced by changes in the Bacillota/Bacteroidota (B/B) ratio and a reduction in Pseudomonadota abundance. Metabolomic analyses further revealed that HAMSIAA was associated with modulation of the purine salvage pathway, including downregulation of hypoxanthine guanine phosphoribosyltransferase (HGPRT) and altered levels of metabolites such as inosine and xanthine, which may contribute to its immunoprotective effects. Discussion Collectively, the present findings suggest that HAMSIAA is a promising functional food ingredient for the prophylactic mitigation of chemotherapy induced immunosuppression, and provide support for its translational application in the field of immunonutrition.

Read PDF

Similar papers

Aug 2026

Immunoregulatory Activity of Chinese Yam Polysaccharides on Cyclophosphamide-Induced Immunosuppression Mice via Regulating Gut Microbiota and Metabolic Pathway

It is suggested that CYPs potentially improve the immune-related indicators in CTX-induced immunosuppressed mice, accompanied by changes in immune organ integrity, gut microbiota composition, and host metabolic pathways.

Liu-Jun Wang, Yi Zheng, Zhen Zhao et al. · 0 citations
Sep 2026

Mannatide modulates immune response and gut microbiota in cyclophosphamide-induced immunosuppressed BALB/c mice.

It is highlighted that Mannatide is associated with immune recovery in CTX-treated mice, accompanied by changes in gut microbiota, SCFA production, and immune-related signalling pathways, and provide insights for adjuvant therapies targeting the gut-immune axis.

Yan-Jiao Feng, Yue Zeng, Xue Zhang et al. · 0 citations
Open access Sep 2026

Food derived raffinose attenuates cyclophosphamide-induced immunosuppression in mice with associated changes in gut microbiota, short-chain fatty acids and intestinal barrier integrity.

BACKGROUND Cyclophosphamide (CTX)-induced immunosuppression is accompanied by systemic immune impairment and intestinal dysbiosis. This study evaluated whether raffinose (Raf), a food-derived prebiotic trisaccharide, is associated with improved immune and intestinal outcomes during CTX challenge. RESULTS Forty male I...

Peng Zhang, Tian-Yi Zhang, Qi-Cheng Lu et al. · 0 citations
Sep 2026

Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity.

BACKGROUND AND PURPOSE This study investigated the therapeutic effects and gut-liver axis-related mechanisms of tetramethylpyrazine (TMP) in metabolic dysfunction-associated steatohepatitis (MASH). EXPERIMENTAL APPROACH Male C57BL/6 mice were fed a methionine- and choline-deficient (MCD) diet for 6 weeks to establish...

Xiao-Li He, Lin-Zhang Zhang, Ya-Di Zhu et al. · 0 citations
Open access Sep 2026

Immunomodulatory effects of Sanghuangporus sanghuang polysaccharide SSP1 in cyclophosphamide-induced immunosuppressed mice: associations with gut microbiota, short-chain fatty acids, and metabolic remodeling

Introduction Immunosuppression induced by chemotherapeutic agents such as cyclophosphamide (CTX) is frequently associated with gut microbiota dysbiosis. Sanghuangporus sanghuang polysaccharide (SSP1) possesses immunomodulatory potential; however, its effects on mucosal immunity and the gut microbiota remain unclear. Me...

Kun Liu, Xin-Yao Fu, Yi-Hang Liu et al. · 0 citations
Open access Sep 2026

Theabrownin from Pu-erh Tea Restores Intestinal Immunity via Gut Microbiota–Metabolite Network in Immunosuppressed Mice

Theabrownin (TB), a polymeric pigment derived from ripened Pu-erh tea, demonstrates beneficial effects on lipid reduction, weight management, and mitigation of metabolic syndrome. However, the role of TB in restoring immune function in vivo has not been studied. This study evaluated the therapeutic effects and underlyi...

Lei Zhao, An-Ding Zhu, Jin-ping Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.